These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 16226681)

  • 1. Conduction abnormalities in nonischemic dilated cardiomyopathy: basic mechanisms and arrhythmic consequences.
    Akar FG; Tomaselli GF
    Trends Cardiovasc Med; 2005 Oct; 15(7):259-64. PubMed ID: 16226681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms underlying conduction slowing and arrhythmogenesis in nonischemic dilated cardiomyopathy.
    Akar FG; Spragg DD; Tunin RS; Kass DA; Tomaselli GF
    Circ Res; 2004 Oct; 95(7):717-25. PubMed ID: 15345654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular repolarization heterogeneity as an arrhythmic substrate in heart failure.
    Akar FG
    Minerva Cardioangiol; 2010 Apr; 58(2):205-12. PubMed ID: 20440250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A comparative analysis of rhythm and conduction disorders in patients with dilated cardiomyopathy and chronic myocarditis].
    Naumov VG; Gabrusenko SA; Shvarneva GG; Zhdanov VS; Belenkov IuN
    Ter Arkh; 1995; 67(9):63-6. PubMed ID: 7495048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.
    Salerno-Uriarte JA; De Ferrari GM; Klersy C; Pedretti RF; Tritto M; Sallusti L; Libero L; Pettinati G; Molon G; Curnis A; Occhetta E; Morandi F; Ferrero P; Accardi F;
    J Am Coll Cardiol; 2007 Nov; 50(19):1896-904. PubMed ID: 17980258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrates for sudden cardiac death.
    Case CL
    Pediatr Clin North Am; 2004 Oct; 51(5):1223-7. PubMed ID: 15331281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of statin therapy on arrhythmic events and survival in patients with nonischemic dilated cardiomyopathy.
    Goldberger JJ; Subacius H; Schaechter A; Howard A; Berger R; Shalaby A; Levine J; Kadish AH;
    J Am Coll Cardiol; 2006 Sep; 48(6):1228-33. PubMed ID: 16979011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ischemia-induced arrhythmia: the role of connexins, gap junctions, and attendant changes in impulse propagation.
    Cascio WE; Yang H; Muller-Borer BJ; Johnson TA
    J Electrocardiol; 2005 Oct; 38(4 Suppl):55-9. PubMed ID: 16226075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Arrhythmia-induced dilated cardiomyopathies].
    Bounhoure JP; Boveda S; Albenque JP
    Bull Acad Natl Med; 2006 Jun; 190(6):1225-35; discussion 1235-6. PubMed ID: 17195405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular electrophysiologic mechanisms of cardiac arrhythmias.
    Wit AL
    Cardiol Clin; 1990 Aug; 8(3):393-409. PubMed ID: 2205382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventricular fibrillation in two cases with dilated cardiomyopathy and mechanical alternans.
    Kodama M; Ramadan MM; Mitsuma W; Okamura K; Kashimura T; Tachikawa H; Ito M; Fuse K; Hirono S; Okura Y; Kato K; Hanawa H; Watanabe K; Aizawa Y
    Pacing Clin Electrophysiol; 2005 Dec; 28(12):1347-9. PubMed ID: 16403167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immune status of patients with cardiac arrhythmias: idiopathic and in primary heart disease].
    Bekbosynova MS; Pichugin AV; Novikova DS; Gabrusenko SA; Kozhemiakina ESh; Ataullakhanova DM; Golitsyn SP; Ataullakhanov RI
    Ter Arkh; 2006; 78(9):52-60. PubMed ID: 17076226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathology of sudden cardiac death in patients with ischemic heart disease--arrhythmology for anatomic pathologists.
    Saffitz JE
    Cardiovasc Pathol; 2005; 14(4):195-203. PubMed ID: 16009318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of cardiac autonomic regulation and ventricular repolarization after off-pump coronary artery bypass grafting.
    Kalisnik JM; Avbelj V; Trobec R; Ivaskovic D; Vidmar G; Troise G; Gersak B
    Heart Surg Forum; 2006; 9(3):E661-7. PubMed ID: 16753938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological therapy of arrhythmias complicating dilated cardiomyopathy--implications of the arrhythmogenic substrate.
    Gumbrielle T; Campbell RW
    Eur Heart J; 1993 Sep; 14 Suppl E():103-6. PubMed ID: 8223746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of ventricular arrhythmias.
    Binah O; Rosen MR
    Circulation; 1992 Jan; 85(1 Suppl):I25-31. PubMed ID: 1728502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New pathogenetic mechanisms of idiopathic dilated cardiomyopathy: changes in coronary microcirculation].
    Neglia D
    Recenti Prog Med; 2003 Jun; 94(6):247-52. PubMed ID: 12793095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping arrhythmias in the failing heart: from Langendorff to patient.
    Akar JG; Akar FG
    J Electrocardiol; 2006 Oct; 39(4 Suppl):S19-23. PubMed ID: 16920143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging myocardial scar and arrhythmic risk prediction--a role for the electrocardiogram?
    Strauss DG; Wu KC
    J Electrocardiol; 2009; 42(2):138.e1-8. PubMed ID: 19185315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of levels of matrix metalloproteinase-2 and -3 in patients with ischemic cardiomyopathy versus nonischemic cardiomyopathy.
    Tziakas DN; Chalikias GK; Papaioakeim M; Hatzinikolaou EI; Stakos DA; Tentes IK; Papanas N; Kortsaris A; Maltezos E; Hatseras DI
    Am J Cardiol; 2005 Nov; 96(10):1449-51. PubMed ID: 16275197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.